Trials / Completed
CompletedNCT04327466
Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants
Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants: A Randomized Crossover Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 3 Days
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effect of non-invasive high frequency oscillations applied via a highflow nasal cannula ('Osciflow') compared to highflow nasal cannula without oscillations (HF) on desaturations and bradycardia in premature infants. It uses a crossover design. Infants are randomized to begin the study with either Osciflow or HF. Both modes are applied for 4 hours. Infants are monitored with an oximetry sensor to measure peripheral oxygen saturation (SpO2) and pulse rate, and with a transcutaneous CO2-transducer. Further measurements include respiratory rate and 'Bernese pain scale' evaluated by nursing staff and Electrical Impedance Tomography (EIT) in a subset of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Osciflow | Osciflow is a non-invasive high frequency oscillatory ventilation support delivered via a highflow nasal cannula for four hours (one hour wash-out, three hours measurement period). |
| DEVICE | Highflow | Standard highflow therapy without oscillations delivered via a highflow nasal cannula for four hours (one hour wash-out, three hours measurement period). |
Timeline
- Start date
- 2020-05-22
- Primary completion
- 2021-11-26
- Completion
- 2021-11-26
- First posted
- 2020-03-31
- Last updated
- 2024-07-08
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04327466. Inclusion in this directory is not an endorsement.